From: EPB41L4A-AS1 and UNC5B-AS1 have diagnostic and prognostic significance in osteosarcoma
Parameter | Cumulative overall survival | ||
---|---|---|---|
HR | 95%CI | P | |
EPB41L4A-AS1 (High vs. Low) | 5.997 | 1.845–19.486 | 0.003** |
UNC5B-AS1 (High vs. Low) | 5.911 | 1.828–19.18 | 0.003** |
Age (≥ 18 years vs. < 18 years) | 1.144 | 0.437–2.996 | 0.784 |
Gender (Male vs. Female) | 2.085 | 0.761–5.713 | 0.153 |
Tumor site | |||
Femur | Reference | ||
Tibia | 0.509 | 0.134–1.927 | 0.320 |
Humeral bone | 1.078 | 0.265–4.381 | 0.917 |
Other | 1.134 | 0.226–5.684 | 0.878 |
SSS stage (III vs. I–II) | 4.676 | 1.430–15.291 | 0.011* |
LDH (≥ 850 IU/L vs. < 850 IU/L) | 1.842 | 0.667–5.086 | 0.238 |
ALP (≥ 280 IU/L vs. < 280 IU/L) | 1.452 | 0.566–3.724 | 0.437 |